(1)
Lebwohl, M.; Bukhalo, M.; Gold, L. S.; Pelle, M.; Glick, B.; Llamas-Velasco, M.; Sanchez-Rivera, S.; Zhan, T.; Drogaris, L.; Douglas, K.; St. John, G.; Espaillat, R.; Bissonnette, R. A Phase 3b Study Evaluating Safety and Efficacy of Risankizumab in Adult Patients With Moderate-to-Severe Plaque Psoriasis With Palmoplantar (Non-Pustular) Involvement. J of Skin 2023, 7, s256.